CD4 (SK3), FITC; Contains CD4 FITC with gelatin and 0.1% sodium Azide. Catalog number 340133 ...
FDA Device Recall #Z-2817-2015 — Class III — August 27, 2015
Recall Summary
| Recall Number | Z-2817-2015 |
| Classification | Class III — Low risk |
| Date Initiated | August 27, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton, Dickinson and Company, BD Biosciences |
| Location | San Jose, CA |
| Product Type | Devices |
| Quantity | 128 units |
Product Description
CD4 (SK3), FITC; Contains CD4 FITC with gelatin and 0.1% sodium Azide. Catalog number 340133 in vitro diagnostic used in Hematology: The SK3 monoclonal antibody reacts with human CD4, a 59-kDa cell surface receptor expressed by a majority of thymocytes, a subpopulation of mature T helper cells, and at low levels on monocytes. CD4 is a receptor for the human immunodeficiency virus (HIV).
Reason for Recall
CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC.
Distribution Pattern
Worldwide Distribution. US nationwide (TX, CA, NC, OH, SD, PA, CT, UT, MD, TX, GA), Argentina, Taiwan, Australia, Japan, China, New Zealand, Chile and Colombia.
Lot / Code Information
Catalog Number 340133; lot # 5112711, Expiration date: 30 Nov 2016.
Other Recalls from Becton, Dickinson and Company, BD Bio...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2351-2024 | Class II | BD Multitest 6-Color TBNK CE-IVD, REF: 644611; ... | May 8, 2024 |
| Z-0641-2024 | Class II | CD11b APC: ASR, REF: 340936, and CE, REF: 333143 | Oct 25, 2023 |
| Z-0173-2023 | Class II | BD Multitest 6-Color TBNK with optional BD Truc... | Oct 3, 2022 |
| Z-0172-2023 | Class II | BD Trucount Tubes (Cat. No. 663028), used for d... | Oct 3, 2022 |
| Z-0171-2023 | Class II | BD Trucount Tubes (Cat. No. 340334), used for d... | Oct 3, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.